Turner Heather D — SEC Form 4 filings
SEC reporting owner CIK 1403571. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-05.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-11-19 to 2026-05-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) | Director | 4 | — | — | 6 |
| LB PHARMACEUTICALS INC (LBRX) | Chief Executive Officer, Director | 1 | — | — | 5 |
| Avalyn Pharma Inc. (AVLN) | Director | 1 | — | — | 1 |
Form 4 filings — Turner Heather D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 1,697 (derivative) | EDGAR |
| 2026-05-01 | 4 | Avalyn Pharma Inc. (AVLN) | Grant/award (A): 26,978 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 1,697 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | LB PHARMACEUTICALS INC (LBRX) | Disposition to issuer (D): 175,706 (derivative) · Grant/award (A): 175,706 (derivative) · Disposition to issuer (D): 7,857 (derivative) · Grant/award (A): 7,857 (derivative) · Grant/award (A): 971,828 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 64,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1403571 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →